Advertisement

#Covid19

Comparing Death Tolls From Covid to Past Wars Is Fraught

Feb 08, 2021

This story also ran on NPR. It can be republished for free. Counting the dead is one of the first, somber steps in reckoning with an event of enormous tragic scope, be it war, a ...

California’s Rural Counties Endure a Deadly Covid Winter

Feb 08, 2021

Covid-19’s fierce winter resurgence in California is notable not only for the explosion in overall cases and deaths in the state’s sprawling urban centers. This latest surge spilled across...

Covid-19: Weekly Testing, 2-Week Isolation is Cost Effective in Areas with High Spread

Feb 08, 2021

Modeling study considered testing strategies by community spread In communities where Covid-19 is spreading rapidly, weekly population-wide testing coupled with a two-week isolation period for thos...

Covid-19: Johnson & Johnson Seeks EUA for Its Coronavirus Vaccine

Feb 08, 2021

Submission based on data from phase III ENSEMBLE trial Johnson & Johnson announced that it has issued an Emergency Use Authorization (EUA) application to the FDA for its single-dose Covid-19 va...

Hard Bargain: Biden and Congress Agree on Basic Relief, but Chasms Remain on Covid Plan

Feb 07, 2021

Use Our Content It can be republished for free. President Joe Biden and a group of Republicans agreed this week on how much Congress should spend on vaccine distribution, covid-19 ...

Covid-Certified Businesses Try to Woo Leery Patrons

Feb 07, 2021

GRAND JUNCTION, Colo. — On a sunny Saturday in January, Ruth Hatfield was sitting with a friend’s dog on a sidewalk bench in downtown Grand Junction. Back home in Snowmass Village, 120 miles a...

COVID-19 Outcomes Worse for Persons Living With Diagnosed HIV

Feb 05, 2021

THURSDAY, Feb. 4, 2021 (HealthDay News) -- Persons living with HIV who are diagnosed with COVID-19 are more likely to require hospitalization and to die, according to a study published online Feb. 3 i...

High Efficacy Reported for Sputnik V COVID-19 Vaccine

Feb 05, 2021

THURSDAY, Feb. 4, 2021 (HealthDay News) -- A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V), has 91.6 percent efficacy against COVID-19, according to a study publis...

100 Million Covid Shots in 100 Days Doesn’t Get Us Back to Normal

Feb 05, 2021

  This story also ran on PolitiFact. It can be republished for free. April 30 will mark the end of the first 100 days of President Joe Biden’s tenure. That’s a benchmark presidents often se...

Covid-19: Black Adults Skeptical of Vaccines, U.S. Healthcare

Feb 05, 2021

NFID survey underscores need to address disparities and increase vaccine education Results from a survey commissioned by the National Foundation for Infectious Diseases (NFID) revealed very low con...

Long-Haul Covid Cases Cast New Light on Chronic Fatigue Sufferers

Feb 04, 2021

Four weeks after San Diego pediatric nurse Jennifer Minhas fell ill with covid-19 last March, her cough and fever had resolved, but new symptoms had emerged: chest pain, an elevated heart rate and cru...

COVID Vaccine – Four Lessons from Speedy Development

Feb 04, 2021

The development of a COVID vaccine is one of the most closely watched human experiments in modern medical history. I’ve been thinking how this has played out. What were the broader forces that allow...

One-Third of U.S. Adults Likely to Refuse a COVID-19 Vaccine

Feb 04, 2021

Roughly one-third of Americans say they will decline a COVID-19 vaccine, according to research published in Social Science & Medicine. Researchers assessed vaccine intention among 5,009 US adults ...

Covid-19: Single-Dose Vax May Benefit More People

Feb 04, 2021

Delaying second doses could also free up scarce supply A modeling study suggests a greater population-level benefit for a single-dose Covid-19 vaccination strategy compared to the current 2-dose stra...

Two Billion COVID-19 Vaccine Doses From BioNTech Expected This Year

Feb 04, 2021

A boost in manufacturing should enable Germany’s BioNTech to produce 2 billion doses of its COVID-19 vaccine this year, the company says. With three manufacturing sites in the United States and thre...

Russia’s Covid-19 Vaccine 91.6% Effective, Interim Phase III Data Show

Feb 04, 2021

More than 2 million in Russia have received the vaccine Peer-reviewed, interim phase III data from a trial of a Covid-19 vaccine developed in Russia showed an overall efficacy of 91.6%, with protec...

Covid-19: Oxford/AstraZeneca Vax May Reduce Viral Transmission

Feb 04, 2021

AZD1222 appears effective, reduces positive PCR tests Early results from three trials assessing the safety and efficacy of the Oxford University/AstraZeneca Covid-19 vaccine, AZD1222, suggest that ...

When Your Chance for a Covid Shot Comes, Don’t Worry About the Numbers

Feb 03, 2021

Use Our Content It can be republished for free. When getting vaccinated against covid-19, there’s no sense being picky. You should take the first authorized vaccine that̵...

Moderna Wants to Increase Number of Doses in COVID-19 Vaccine Vials

Feb 03, 2021

TUESDAY, Feb. 2, 2021 (HealthDay News) -- A decision on whether to allow Moderna to increase the number of doses in its vials of COVID-19 vaccine is expected from the U.S. Food and Drug Administration...

Psychological Distress High Among Students During COVID-19

Feb 03, 2021

TUESDAY, Feb. 2, 2021 (HealthDay News) -- The prevalence of self-reported psychological distress among students has been relatively high during the COVID-19 pandemic, according to a study published on...

SUBSPECIALTIES

Advertisement